Spruce Biosciences Inc Forecast, price target & analysts
Spruce Biosciences Inc Target price 2025 - Analyst rating & recommendation
Spruce Biosciences Inc Classifications & Recommendation:
Spruce Biosciences Inc Price Target
| Target Price | $1.02 |
| Price | $0.10 |
| Potential |
889.33%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Spruce Biosciences Inc 2026 .
The average Spruce Biosciences Inc target price is $1.02.
This is
889.33%
register free of charge
$1.05
918.43%
register free of charge
$1.01
879.63%
register free of charge
|
|
| A rating was issued by 9 analysts: 0 Analysts recommend Spruce Biosciences Inc to buy, 6 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Spruce Biosciences Inc stock has an average upside potential 2026 of
889.33%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 4.91 | 1.02 |
| 51.34% | 79.23% | |
| EBITDA Margin | -1,142.77% | -8,704.60% |
| 122.08% | 661.71% | |
| Net Margin | -1,080.24% | -2,871.64% |
| 127.46% | 165.83% |
5 Analysts have issued a sales forecast Spruce Biosciences Inc 2025 . The average Spruce Biosciences Inc sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Spruce Biosciences Inc EBITDA forecast 2025. The average Spruce Biosciences Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $-56.1m | 8.07% |
|---|---|---|
| 2025 |
$-88.8m
58.24%
Unlock
|
|
EBITDA Margin
| 2024 | -1,142.77% | 122.08% |
|---|---|---|
| 2025 |
-8,704.60%
661.71%
Unlock
|
|
5 Spruce Biosciences Inc Analysts have issued a net profit forecast 2025. The average Spruce Biosciences Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Net Margin
| 2024 | -1,080.24% | 127.46% |
|---|---|---|
| 2025 |
-2,871.64%
165.83%
Unlock
|
|
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.29 | -0.69 |
| 4.03% | 46.51% | |
| P/E | negative | |
| EV/Sales | negative |
5 Analysts have issued a Spruce Biosciences Inc forecast for earnings per share. The average Spruce Biosciences Inc EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the Spruce Biosciences Inc stock is valued at an EV/Sales of
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | -6.65 | 46.48% |
|---|---|---|
| 2025 |
-32.02
381.50%
Unlock
|
|
P/S ratio
| Current | 0.89 | 64.13% |
|---|---|---|
| 2025 |
4.26
380.91%
Unlock
|
|
Spruce Biosciences Inc...
Current Spruce Biosciences Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| RBC Capital |
Locked
➜
Locked
|
Locked | Apr 16 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Dec 16 2024 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Dec 12 2024 |
| JMP Securities |
Locked
➜
Locked
|
Locked | Dec 11 2024 |
| Oppenheimer |
Locked
➜
Locked
|
Locked | Dec 11 2024 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Dec 11 2024 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Nov 12 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
RBC Capital:
Locked
➜
Locked
|
Apr 16 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Dec 16 2024 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Dec 12 2024 |
|
Locked
JMP Securities:
Locked
➜
Locked
|
Dec 11 2024 |
|
Locked
Oppenheimer:
Locked
➜
Locked
|
Dec 11 2024 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Dec 11 2024 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Nov 12 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
